Cas 1606126-33-3,2-[4-chloro-5-(3-fluorophenyl)-3-phenyl-pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone

1606126-33-3

Post Buying Request

Basic information

Product Name: 2-[4-chloro-5-(3-fluorophenyl)-3-phenyl-pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone
Synonyms: 2-[4-chloro-5-(3-fluorophenyl)-3-phenyl-pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone
CAS NO:1606126-33-3
Molecular Formula:
Molecular Weight: 435.888
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-[4-chloro-5-(3-fluorophenyl)-3-phenyl-pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone(CAS DataBase Reference)
NIST Chemistry Reference: 2-[4-chloro-5-(3-fluorophenyl)-3-phenyl-pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone(1606126-33-3)
EPA Substance Registry System: 2-[4-chloro-5-(3-fluorophenyl)-3-phenyl-pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone(1606126-33-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1606126-33-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1606126-33-3 Suppliers

Recommended suppliers

1606126-33-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1606126-33-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,0,6,1,2 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1606126-33:
(9*1)+(8*6)+(7*0)+(6*6)+(5*1)+(4*2)+(3*6)+(2*3)+(1*3)=133
133 % 10 = 3
So 1606126-33-3 is a valid CAS Registry Number.

1606126-33-3Upstream product

1606126-33-3Downstream Products

1606126-33-3Relevant academic research and scientific papers

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

-

Paragraph 0160; 0161; 0162; 0163, (2014/05/08)

Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic retinal degenerations, age-related macular degeneration and Usher Syndrome, and hearing loss associated with Usher Syndrome are described herein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1606126-33-3